Your browser doesn't support javascript.
loading
Multivariable time-dependent analysis of the impact of azacitidine in patients with lower-risk myelodysplastic syndrome and unfavorable specific lower-risk score.
Falantes, Jose; Delgado, Regina García; Calderón-Cabrera, Cristina; Márquez-Malaver, Francisco J; Valcarcel, David; de Miguel, Dunia; Bailén, Alicia; Bargay, Joan; Bernal, Teresa; González-Porras, Jose R; Tormo, Mar; Ramos, Fernando; Andreu, Rafael; Xicoy, Blanca; Nomdedeu, Benet; Brunet, Salut; Sánchez, Joaquín; Jurado, Antonio Fernández; Bonanad, Santiago; Pérez-Simón, Jose Antonio; Sanz, Guillermo.
Affiliation
  • Falantes J; Hospital Universitario Virgen del Rocío, Sevilla. Instituto de Biomedicina de Sevilla (IBIS)/CSIC/Universidad de Sevilla, Spain. Electronic address: josef.falantes.sspa@juntadeandalucia.es.
  • Delgado RG; Hospital Universitario Virgen de la Victoria, Málaga, Spain.
  • Calderón-Cabrera C; Hospital Universitario Virgen del Rocío, Sevilla. Instituto de Biomedicina de Sevilla (IBIS)/CSIC/Universidad de Sevilla, Spain.
  • Márquez-Malaver FJ; Hospital Universitario Virgen del Rocío, Sevilla. Instituto de Biomedicina de Sevilla (IBIS)/CSIC/Universidad de Sevilla, Spain.
  • Valcarcel D; Hospital Universitario Vall d' Hebron, Barcelona, Spain.
  • de Miguel D; Hospital Universitario de Guadalajara, Guadalajara, Spain.
  • Bailén A; Hospital Carlos Haya, Málaga, Spain.
  • Bargay J; Hospital Son Llatzer, Palma de Mallorca, Spain.
  • Bernal T; Hospital Universitario Central de Asturias, Spain.
  • González-Porras JR; Hospital Clínico Universitario de Salamanca, Salamanca, Spain.
  • Tormo M; Hospital Clínico Universitario de Valencia, Valencia, Spain.
  • Ramos F; Hospital General de León, León, Spain.
  • Andreu R; Hospital Doctor Peset, Valencia, Spain.
  • Xicoy B; Hospital Germans Trias i Pujol, Badalona, Spain.
  • Nomdedeu B; Hospital Clinic, Barcelona, Spain.
  • Brunet S; Hospital Santa Creu i Sant Pau, Barcelona, Spain.
  • Sánchez J; Hospital Reina Sofía, Córdoba, Spain.
  • Jurado AF; Hospital Juan Ramón Jiménez, Huelva, Spain(1).
  • Bonanad S; Hospital Universitario de la Ribera, Valencia, Spain.
  • Pérez-Simón JA; Hospital Universitario Virgen del Rocío, Sevilla. Instituto de Biomedicina de Sevilla (IBIS)/CSIC/Universidad de Sevilla, Spain.
  • Sanz G; Hospital Universitario y Politécnico La Fe, Valencia, Spain(2).
Leuk Res ; 39(1): 52-7, 2015 Jan.
Article in En | MEDLINE | ID: mdl-25487012
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Azacitidine / Myelodysplastic Syndromes / Antimetabolites, Antineoplastic Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Leuk Res Year: 2015 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Azacitidine / Myelodysplastic Syndromes / Antimetabolites, Antineoplastic Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Leuk Res Year: 2015 Document type: Article